The PD-L1 Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-149348 |
| Réf. fabricant | 18012718 |
| À utiliser avec (application) | Western Blot |
| Lignée cellulaire | The lysate was created in HEK293T cells, using plasmid ID RC215316 and based on accession number NP_54862. The protein contains a C-terminal DDK tag. |
| Quantité | 0.1 mg |
| Tampon de stockage | RIPA buffer |
| Pureté | Protein |
| Spécificité du test | Homo sapiens CD274, mRNA. |
| Contenu et stockage | Store at -80 C. Avoid freeze-thaw cycles. |
| Catégorie de recherche | Autoimmune Diseases, Cancer, Cellular Markers, Checkpoint signaling, Immune System Diseases, Immunology, Signal Transduction, Tumor Biomarkers, Tumor Suppressors |
| Cible | PD-L1 |
| Synonyme | Avelumab, B7-H, B7-H1, B7H1PDCD1L1, CD274 antigenMGC142294, CD274 molecule, PDCD1LG1MGC142296, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1 |
| Symbole de gène(s) | CD274 |
| Protein State | Native |
